Differentiation of F9 embryonal carcinoma cells. Differences in the effects of retinoic acid, 5-bromodeoxyuridine, and N'-N'-dimethylacetamide.

We found that monolayer cultures of F9 cells induced to differentiate with trans-retinoic acid (RA) contain two major subpopulations of cells. These two cell types can be distinguished by their cellular morphology, their pattern of laminin accumulation, and their ability to undergo further differentiation in response to N6-O2-dibutyryl adenosine 3':5' cyclic monophosphoric acid (dBcAMP). Furthermore, the developmental pathway induced by RA appears to lead to two alternative pathways, and differentiation at the branch point is either directly or indirectly controlled by cAMP. Differentiation along one branch of this pathway can be induced by 5-bromodeoxyuridine, whereas differentiation along an unrelated pathway is induced by N'-N'-dimethylacetamide. In all cases, differentiation is closely paralleled by suppression of the tumorigenic phenotype, indicating that these two processes are tightly linked and probably share a common step.

[1]  E. Moore,et al.  A variant F9 embryonal carcinoma cell line which undergoes incomplete differentiation in retinoic acid. , 1985, Cancer research.

[2]  D. Balicki,et al.  Lack of correlation between loss of anchorage-independent growth and levels of transformation-specific p53 protein in retinoic acid-treated F9 embryonal carcinoma cells. , 1985, Experimental cell research.

[3]  C. Isacke,et al.  Teratocarcinoma cells exhibit growth cooperativity in vitro , 1983, Journal of cellular physiology.

[4]  J. Wartiovaara,et al.  Nerve growth factor induces adrenergic neuronal differentiation in F9 teratocarcinoma cells , 1983, Nature.

[5]  W. Anderson,et al.  A new differentiated cell line (Dif 5) derived by retinoic acid treatment of F9 teratocarcinoma cells capable of extracellular matrix production and growth in the absence of serum. , 1983, Experimental cell research.

[6]  Y. Nishimune,et al.  Induction of teratocarcinoma cell differentiation. Effect of the inhibitors of DNA synthesis. , 1983, Experimental cell research.

[7]  M. McBurney,et al.  The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line. , 1983, Developmental biology.

[8]  R. Hynes,et al.  Fibronectins: multifunctional modular glycoproteins , 1982, The Journal of cell biology.

[9]  M. McBurney,et al.  Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line , 1982, Nature.

[10]  R. Oshima.  Identification and immunoprecipitation of cytoskeletal proteins from murine extra-embryonic endodermal cells. , 1981, The Journal of biological chemistry.

[11]  E. Adamson,et al.  Cell interactions modulate embryonal carcinoma cell differentiation into parietal or visceral endoderm , 1981, Nature.

[12]  S. Strickland.  Mouse teratocarcinoma cells: Prospects for the study of embryogenesis and neoplasia , 1981, Cell.

[13]  N. Ringertz,et al.  Retinoic acid-induced differentiation of F9 embryonal carcinoma cells. , 1981, Experimental cell research.

[14]  E. Linney,et al.  Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells , 1981, Cell.

[15]  C. Croce,et al.  Expression of H–2, laminin and SV40T and TASA on differentiation of transformed murine teratocarcinoma cells , 1980, Nature.

[16]  S. Strickland,et al.  Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMP , 1980, Cell.

[17]  E. Kuff,et al.  Induction of neural-like cells and acetylcholinesterase activity in cultures of F9 teratocarcinoma treated with retinoic acid and dibutyryl cyclic adenosine monophosphate. , 1980, Developmental biology.

[18]  B. Hogan.  High molecular weight extracellular proteins synthesized by endoderm cells derived from mouse teratocarcinoma cells and normal extraembryonic membranes. , 1980, Developmental biology.

[19]  F. Dixon,et al.  Chemically induced bidirectional differentiation of embryonal carcinoma cells in vitro. , 1979, The American journal of pathology.

[20]  G. Khoury,et al.  Differentiation as a requirement for simian virus 40 gene expression in F-9 embryonal carcinoma cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Foidart,et al.  Laminin--a glycoprotein from basement membranes. , 1979, The Journal of biological chemistry.

[22]  D. Solter,et al.  The induction of antigenic changes in a teratocarcinoma stem cell line (F9) by retinoic acid. , 1979, Developmental biology.

[23]  D. Solter,et al.  Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Strickland,et al.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid , 1978, Cell.

[25]  T. Chen,et al.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. , 1977, Experimental cell research.

[26]  L. Klein,et al.  Lowry assay of dilute protein solutions containing high concentrations of Triton X-100. , 1975, Analytical biochemistry.

[27]  G. Martin,et al.  Teratocarcinomas as a model system for the study of embryogenesis and neoplasia , 1975, Cell.

[28]  V. Freedman,et al.  Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. , 1974, Cell.

[29]  G. B. Pierce,et al.  Neoplastic differentiation: Characteristics of cell lines derived from a murine teratocarcinoma , 1974, Journal of cellular physiology.

[30]  B. Ephrussi,et al.  Alkaline phosphatase activity in mouse teratoma. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R G HAM,et al.  CLONAL GROWTH OF MAMMALIAN CELLS IN A CHEMICALLY DEFINED, SYNTHETIC MEDIUM. , 1965, Proceedings of the National Academy of Sciences of the United States of America.